REDWOOD CITY, Calif., April 18, 2008 (PRIME NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today announced that on April 17, 2008, it received a Staff Determination Letter from NASDAQ indicating that the Company has not gained compliance with the $1.00 minimum bid price requirement for continued listing on the NASDAQ Global Market set forth in Marketplace Rule 4450(a)(5), and that the Company's securities are therefore subject to delisting. The Company had announced on October 23, 2007, that NASDAQ had notified the Company of its noncompliance with the minimum bid rule and that the Company would have six months, or until April 16, 2008, to regain compliance.
